|
|
|
Transforming Tomorrow, Today
|
News & Updates from the National Brain Tumor Society
|
|
|
|
|
|
|
January 2015
|
|
Spotlight
|
Celebrating Progress in 2014 & Building Hope for a Successful 2015
|
The dawn of a New Year is a time for patient advocacy organizations like the National Brain Tumor Society to review progress made in the previous 12 months, and plan for how to create even greater impact for the brain tumor community in the coming year. As such, one of our traditions is our yearly update for the community on how all of your generosity and support is helping us move our mission for better treatments, and ultimately a cure for brain tumors, forward.
We've compiled a list of 10 of our proudest achievements of the year (in no particular order), which we were only able to accomplish with the many contributions made by our dedicated community, no matter how you took action with us in 2014. Read More
|
|
From the Blog
|
December 8, 2014
|
National Brain Tumor Society Names New Chief Executive Officer
|
National Brain Tumor Society set out on a national search to find an experienced executive capable of leading our organization through its next phase of growth. Sally M. Davis rose to the top during this exhaustive process. Sally is a successful senior-level fundraiser, as well as experienced executive and will be an asset for the National Brain Tumor Society during this important time in brain tumor research and development. Read More
|
|
December 19, 2014
|
Defeat GBM Research Collaborative Produces Important Discovery
|
Defeat GBM's Discovery Team believes they may have identified a mechanism by which glioblastoma multiforme cells become resistant to certain, initially promising treatments. They also believe there might be a way to reverse it. Read More
|
|
December 15, 2014
|
A Step Toward Identifying Risk Factors for Glioma
|
In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors - what causes them to develop. Recently, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a gene called POT1 could be related to an increased risk for developing the brain tumor, oligodendroglioma. Read More
|
|
|
|
|
|
Event Spotlight
Charlotte, NC - Saturday, March 21, 2015
|
|
|
|
|
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.
|
|
|
|